serum; peripheral blood
-
metastasis (promotes); other pathway/process (promotes)
RT-qPCR; Clinical Sample Validation; Cohort Study; Survival Analysis; ROC Analysis
Serum CircERBB2 has diagnostic value for NSCLC, its combined detection with CEA improves diagnostic performance, and high serum CircERBB2 expression is associated with poor prognosis.
CircERBB2 was measured in serum from NSCLC patients, benign lung disease patients, and healthy controls, and was found to be highly expressed in NSCLC. Higher serum CircERBB2 was associated with tumor diameter, lymph node metastasis, TNM stage, increased death-group levels, worse 36-month survival, and good diagnostic performance, especially when combined with CEA. The study did not investigate a molecular mechanism for CircERBB2 in NSCLC.
0.4992
Diagnostic and prognostic value of serum CircERBB2 level in NSCLC and its correlation with clinicopathological features in NSCLC patients.
clinical study